PSMA Imaging and Theranostics: Future Impact to Patient Management– Robert Flavell
August 15, 2018
(Length of presentation: 30 min)
In an interview with Phil Koo, Robert Flavell describes diagnostic and therapeutic applications of new agents in the management of patients with prostate cancer with initial high-risk diagnosis and biochemical recurrence.
Biographies:
Robert R. Flavell, MD, Ph.D., Assistant Professor in Residence Department of Radiology, Section of Nuclear Medicine, University of California, San Francisco
Phillip J. Koo, MD, FACS
Further Related ContentIn an interview with Phil Koo, Robert Flavell describes diagnostic and therapeutic applications of new agents in the management of patients with prostate cancer with initial high-risk diagnosis and biochemical recurrence.
Biographies:
Robert R. Flavell, MD, Ph.D., Assistant Professor in Residence Department of Radiology, Section of Nuclear Medicine, University of California, San Francisco
Phillip J. Koo, MD, FACS
STOMP Trial
Read the full video transcript